Nanocage targets drug site bullseye; Supersized vaccine plant;

> A smart nanocage made of gold and covered with a smart polymer is light-activated to release its medicinal contents--a chemotherapy drug or bactericide, for example--only near the target tissue. Article

> Toronto-based Microbix Biosystems (MBX:TSX) and joint-venture partner Hunan Biopharmaceutical will build what they call "the world's third largest influenza vaccine facility." Announcement

> Russian drugmaker Materia Medica has again turned to contract manufacturer Angel Biotechnology (ABH.L), this time for process development and GMP manufacturing of certain antibodies. Release

> The Royal Pharmaceutical Society has joined forces with Pfizer to launch part two of the manufacturers' anti-counterfeiting campaign. Article

> The Motley Fool provides its unique insights in a face-off of the big three pharma industry distributors. Analysis

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.